drugset / Trial / NCT07420010
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Non-randomizedSequentialOpen-labelTreatment
Summary
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Timeline
- Start
- 2026-03-15
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KT032 | Cell therapy | 1e+06 cells/kg | Intravenous |
| Subject | KT032 | Cell therapy | 2e+06 cells/kg | Intravenous |
| Subject | KT032 | Cell therapy | 3e+06 cells/kg | Intravenous |